Vycor Medical Inc
VYCO· OTC
Filed Nov 14, 2016 · 10-Q · 45 days after period end · 0001493152-16-014827
| Metric | Q3 2016 | Q3 2015 | Q3 2014 | Q3 2013 |
|---|---|---|---|---|
| Revenue | $325.78K | $242.86K | $334.34K | $321.63K |
| Net Income | -$331.90K | -$506.79K | -$1.28M | -$506.91K |
| EPS Diluted | -$0.04 | -$0.05 | -$0.12 | -$0.08 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Vycor Medical Inc · CIK 1424768 · Engraved from SEC EDGAR
ended Sep 30, 2016 · filed Nov 14, 2016 · 45 d after period end